Annual Current Assets
$3.20 M
-$2.18 M-40.48%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual total current assets is $3.20 million, with the most recent change of -$2.18 million (-40.48%) on December 31, 2022.
- During the last 3 years, NAVB annual current assets has risen by +$288.10 thousand (+9.88%).
- NAVB annual current assets is now -94.03% below its all-time high of $53.70 million, reached on December 31, 1996.
Performance
NAVB Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$4.50 M
-$2.50 M-35.71%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly total current assets is $4.50 million, with the most recent change of -$2.50 million (-35.71%) on September 30, 2023.
- Over the past year, NAVB quarterly current assets has dropped by -$2.50 million (-35.71%).
- NAVB quarterly current assets is now -91.61% below its all-time high of $53.70 million, reached on December 31, 1996.
Performance
NAVB Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
NAVB Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.5% | -35.7% |
| 3 y3 years | +9.9% | -35.7% |
| 5 y5 years | -76.8% | -35.7% |
NAVB Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.5% | at low | -35.7% | +284.6% |
| 5 y | 5-year | -50.9% | +9.9% | -55.2% | +284.6% |
| alltime | all time | -94.0% | +9.9% | -91.6% | +284.6% |
Navidea Biopharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $4.50 M(-35.7%) |
| Jun 2023 | - | $7.00 M(+484.9%) |
| Mar 2023 | - | $1.20 M(-62.6%) |
| Dec 2022 | $1.17 M(-7.4%) | $3.20 M(-37.2%) |
| Sep 2022 | - | $5.10 M(+335.6%) |
| Jun 2022 | - | $1.17 M(-49.6%) |
| Mar 2022 | - | $2.32 M(-56.8%) |
| Dec 2021 | $1.26 M(+2.6%) | $5.38 M(-29.7%) |
| Sep 2021 | - | $7.66 M(-23.8%) |
| Jun 2021 | - | $10.04 M(+13.8%) |
| Mar 2021 | - | $8.83 M(+35.2%) |
| Dec 2020 | $1.23 M(-0.4%) | $6.53 M(+36.2%) |
| Sep 2020 | - | $4.79 M(-21.0%) |
| Jun 2020 | - | $6.07 M(+76.0%) |
| Mar 2020 | - | $3.45 M(+18.2%) |
| Dec 2019 | $1.24 M(-13.4%) | $2.92 M(-9.8%) |
| Sep 2019 | - | $3.23 M(-50.0%) |
| Jun 2019 | - | $6.47 M(+100.4%) |
| Mar 2019 | - | $3.23 M(-42.3%) |
| Dec 2018 | $1.43 M(-79.5%) | $5.60 M(-21.6%) |
| Sep 2018 | - | $7.14 M(+8.2%) |
| Jun 2018 | - | $6.60 M(-59.3%) |
| Mar 2018 | - | $16.23 M(+17.3%) |
| Dec 2017 | $6.95 M(+324.9%) | $13.83 M(-8.8%) |
| Sep 2017 | - | $15.17 M(-9.8%) |
| Jun 2017 | - | $16.81 M(-22.5%) |
| Mar 2017 | - | $21.70 M(+100.4%) |
| Dec 2016 | $1.64 M(-31.5%) | $10.83 M(+14.8%) |
| Sep 2016 | - | $9.43 M(+37.5%) |
| Jun 2016 | - | $6.86 M(-31.7%) |
| Mar 2016 | - | $10.04 M(-20.2%) |
| Dec 2015 | $2.39 M(-26.1%) | $12.58 M(-16.0%) |
| Sep 2015 | - | $14.96 M(-23.4%) |
| Jun 2015 | - | $19.53 M(+143.6%) |
| Mar 2015 | - | $8.02 M(-6.8%) |
| Dec 2014 | $3.23 M(+8.2%) | $8.60 M(-38.5%) |
| Sep 2014 | - | $13.98 M(-32.0%) |
| Jun 2014 | - | $20.57 M(-30.3%) |
| Mar 2014 | - | $29.52 M(-20.9%) |
| Dec 2013 | $2.99 M(+120.3%) | $37.33 M(-21.6%) |
| Sep 2013 | - | $47.62 M(+65.8%) |
| Jun 2013 | - | $28.73 M(+138.7%) |
| Mar 2013 | - | $12.03 M(+13.3%) |
| Dec 2012 | $1.35 M(+18.1%) | $10.62 M(-12.8%) |
| Sep 2012 | - | $12.17 M(-34.9%) |
| Jun 2012 | - | $18.69 M(-20.5%) |
| Mar 2012 | - | $23.51 M(-21.8%) |
| Dec 2011 | $1.15 M(+82.2%) | $30.05 M(-8.6%) |
| Sep 2011 | - | $32.88 M(+188.9%) |
| Jun 2011 | - | $11.38 M(-14.0%) |
| Mar 2011 | - | $13.23 M(+29.3%) |
| Dec 2010 | $629.70 K(+57.2%) | $10.23 M(+61.3%) |
| Sep 2010 | - | $6.34 M(-13.2%) |
| Jun 2010 | - | $7.31 M(-15.8%) |
| Mar 2010 | - | $8.68 M(+0.8%) |
| Dec 2009 | $400.60 K(-83.2%) | $8.62 M(-2.2%) |
| Sep 2009 | - | $8.81 M(+50.2%) |
| Jun 2009 | - | $5.87 M(-13.1%) |
| Mar 2009 | - | $6.76 M(-6.7%) |
| Dec 2008 | $2.38 M | $7.24 M(+47.5%) |
| Sep 2008 | - | $4.91 M(-17.9%) |
| Jun 2008 | - | $5.98 M(+49.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $4.01 M(-13.8%) |
| Dec 2007 | $2.42 M(-10.5%) | $4.65 M(+20.2%) |
| Sep 2007 | - | $3.87 M(+6.5%) |
| Jun 2007 | - | $3.63 M(-15.0%) |
| Mar 2007 | - | $4.27 M(-19.9%) |
| Dec 2006 | $2.70 M(-13.5%) | $5.33 M(-2.2%) |
| Sep 2006 | - | $5.46 M(-18.5%) |
| Jun 2006 | - | $6.69 M(-11.1%) |
| Mar 2006 | - | $7.53 M(-10.8%) |
| Dec 2005 | $3.12 M(-20.5%) | $8.45 M(-4.9%) |
| Sep 2005 | - | $8.89 M(-11.9%) |
| Jun 2005 | - | $10.09 M(-7.7%) |
| Mar 2005 | - | $10.93 M(-4.5%) |
| Dec 2004 | $3.93 M(+17.9%) | $11.44 M(+135.9%) |
| Sep 2004 | - | $4.85 M(-7.9%) |
| Jun 2004 | - | $5.27 M(-4.6%) |
| Mar 2004 | - | $5.52 M(+36.2%) |
| Dec 2003 | $3.33 M(-16.4%) | $4.05 M(+35.5%) |
| Sep 2003 | - | $2.99 M(-5.8%) |
| Jun 2003 | - | $3.17 M(+21.4%) |
| Mar 2003 | - | $2.61 M(-15.4%) |
| Dec 2002 | $3.99 M(-16.6%) | $3.09 M(-40.2%) |
| Sep 2002 | - | $5.17 M(-6.5%) |
| Jun 2002 | - | $5.53 M(+3.2%) |
| Mar 2002 | - | $5.36 M(-18.2%) |
| Dec 2001 | $4.78 M(+243.8%) | $6.55 M(-0.9%) |
| Sep 2001 | - | $6.60 M(+14.3%) |
| Jun 2001 | - | $5.78 M(+1.7%) |
| Mar 2001 | - | $5.68 M(-8.1%) |
| Dec 2000 | $1.39 M(-56.2%) | $6.18 M(+27.4%) |
| Sep 2000 | - | $4.85 M(-13.9%) |
| Jun 2000 | - | $5.63 M(+13.1%) |
| Mar 2000 | - | $4.98 M(-24.5%) |
| Dec 1999 | $3.18 M(-20.0%) | - |
| Jun 1999 | - | $6.60 M(-18.5%) |
| Mar 1999 | - | $8.10 M(+1.0%) |
| Dec 1998 | $3.97 M(-67.6%) | $8.02 M(-15.6%) |
| Sep 1998 | - | $9.50 M(-34.5%) |
| Jun 1998 | - | $14.50 M(-31.9%) |
| Mar 1998 | - | $21.30 M(-27.3%) |
| Dec 1997 | $12.27 M(+20.3%) | $29.30 M(-14.3%) |
| Sep 1997 | - | $34.20 M(-15.3%) |
| Jun 1997 | - | $40.40 M(-13.5%) |
| Mar 1997 | - | $46.70 M(-13.0%) |
| Dec 1996 | $10.20 M(+148.8%) | $53.70 M(+21.5%) |
| Sep 1996 | - | $44.20 M(-1.3%) |
| Jun 1996 | - | $44.80 M(+162.0%) |
| Mar 1996 | - | $17.10 M(-14.5%) |
| Dec 1995 | $4.10 M(0.0%) | $20.00 M(-0.5%) |
| Sep 1995 | - | $20.10 M(+33.1%) |
| Jun 1995 | - | $15.10 M(+91.1%) |
| Mar 1995 | - | $7.90 M(-60.5%) |
| Dec 1994 | $4.10 M(+95.2%) | $20.00 M(+185.7%) |
| Sep 1994 | - | $7.00 M(+48.9%) |
| Jun 1994 | - | $4.70 M(-38.2%) |
| Mar 1994 | - | $7.60 M(-27.6%) |
| Dec 1993 | $2.10 M(+425.0%) | $10.50 M(+41.9%) |
| Sep 1993 | - | $7.40 M(-19.6%) |
| Jun 1993 | - | $9.20 M(-17.9%) |
| Mar 1993 | - | $11.20 M(-11.1%) |
| Dec 1992 | $400.00 K | $12.60 M(+168.1%) |
| Sep 1992 | - | $4.70 M |
FAQ
- What is Navidea Biopharmaceuticals annual total current assets?
- What is the all time high annual current assets for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual current assets year-on-year change?
- What is Navidea Biopharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly current assets year-on-year change?
What is Navidea Biopharmaceuticals annual total current assets?
The current annual current assets of NAVB is $3.20 M
What is the all time high annual current assets for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual total current assets is $53.70 M
What is Navidea Biopharmaceuticals annual current assets year-on-year change?
Over the past year, NAVB annual total current assets has changed by -$2.18 M (-40.48%)
What is Navidea Biopharmaceuticals quarterly total current assets?
The current quarterly current assets of NAVB is $4.50 M
What is the all time high quarterly current assets for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly total current assets is $53.70 M
What is Navidea Biopharmaceuticals quarterly current assets year-on-year change?
Over the past year, NAVB quarterly total current assets has changed by -$2.50 M (-35.71%)